Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 35 results for aortic valve stenosis

  1. Monitoring when there is no current need for intervention: What is the most clinically and cost-effective monitoring (type and frequency of test) for adults with asymptomatic mild or moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current need for intervention?

    with asymptomatic mild or moderate heart valve disease (aortic stenosis, aortic regurgitation,...

    Research recommendation
    Published
    16 December 2021

  2. Thoracoscopically assisted mitral valve surgery (HTG157)

    Evidence-based recommendations on thoracoscopically assisted mitral valve surgery. This involves repairing a defective valve through one or more small incisions between the ribs rather than one large incision through the breastbone (sternum).

    HealthTech guidance
    Published
    12 December 2007
    View recommendations

    Sections for HTG157

  3. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of pharmacological management of heart failure for adults with heart failure and severe aortic stenosis, severe aortic regurgitation or severe mitral regurgitation?

    NG208/18 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of...

    Research recommendation
    Published
    16 December 2021

  4. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with severe aortic stenosis?

    NG208/14 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE...

    Research recommendation
    Published
    16 December 2021

  5. Heart valve disease presenting in adults: investigation and management - transcatheter aortic valve implantation (TAVI) to treat aortic stenosis (update)

    In development Reference number: GID-NG10457 Expected publication date: TBC

    NICE guideline
    In development

  6. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with asymptomatic severe heart valve disease (aortic regurgitation, mitral stenosis, mitral regurgitation or tricuspid regurgitation) and no current indication for intervention?

    of test) for adults with asymptomatic severe heart valve disease (aortic regurgitation, mitral stenosis,...

    Research recommendation
    Published
    16 December 2021

  7. Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (HTG353)

    Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available.

    HealthTech guidance
    Last updated
    19 December 2017
    View recommendations

    Sections for HTG353

  8. Cryoablation for atrial fibrillation in association with other cardiac surgery (HTG74)

    Evidence-based recommendations on cryoablation for atrial fibrillation in association with other cardiac surgery. This involves using a probe to freeze the heart tissue to scar it and interrupt the abnormal electrical signals.

    HealthTech guidance
    Published
    25 May 2005
    View recommendations

    Sections for HTG74

  9. Transient loss of consciousness ('blackouts') in over 16s (CG109)

    This guideline covers assessment, diagnosis and referral for people over 16 who have had a transient loss of consciousness (TLoC; also called a blackout). It aims to improve care for people with TLoC by specifying the most effective assessments and recommending when to refer to a specialist.

    Clinical guideline
    Last updated
    21 November 2023
    View recommendations

    Sections for CG109

  10. Forward view - our priority topics

    Our forward view highlights the topics we will prioritise in the coming year.

  11. Indications for interventions – CT or MRI: In adults with asymptomatic severe aortic stenosis what is the prognostic value and cost effectiveness of LVEF measured on cardiac MRI to assess the need for intervention?

    Indications for interventions – CT or MRI: In adults with asymptomatic severe aortic stenosis what is the prognostic value...

    Research recommendation
    Published
    16 December 2021

  12. Balloon valvuloplasty for aortic valve stenosis in adults and children (IPG78)

    We have moved interventional procedures guidance 78 to become HealthTech guidance 49. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Intrapartum care: existing medical conditions and obstetric complications (QS192)

    This quality standard covers care during labour and birth for women who need extra support because they have a medical condition or complications in their current or previous pregnancy. It also covers women who have had no antenatal care. It describes high-quality care in priority areas for improvement. It does not cover the antenatal and postnatal care of pregnant women with mental health conditions, hypertension in pregnancy, diabetes in pregnancy or the organisation of care for pregnant women with complex social factors.

    Quality standard
    Published
    28 February 2020
    View quality statements

    Sections for QS192

  14. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128)

    This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms.

    NICE guideline
    Last updated
    13 April 2022
    View recommendations

    Sections for NG128

  15. Sutureless aortic valve replacement for aortic stenosis (IPG456)

    Interventional procedures, IPG456 - Issued: July 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 624.

    Withdrawn guidance